ELIZABETH BOGGS: Open Payments
NPI 1063723450 · EAST BERNSTADT, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$684 in 33 payments from 8 companies in 2025. Trend: 2023 $482 · 2024 $575 · 2025 $684
Food & beverage: $684
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $330 |
| Novo Nordisk Inc | 11 | $159 |
| ABBVIE INC. | 3 | $54 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $51 |
| GlaxoSmithKline, LLC. | 2 | $40 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $21 |
| Merck Sharp & Dohme LLC | 1 | $15 |
| Lilly USA, LLC | 1 | $14 |
Products named: TEZSPIRE, AIRSUPRA, Rybelsus, VRAYLAR, CAPLYTA, Wegovy, Ozempic, TRELEGY ELLIPTA.
Industry payments across KY — which companies pay providers there.
